REPORT ID 3974

Global Orphan Drugs Market Professional Survey Report 2017

Publish Date
14-Dec-17
Pages
112
Format
Electronic (PDF)

This report studies Orphan Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Novartis AG
    Bristol-Myers Squibb Company
    Celgene Corporation
    F. Hoffmann-La Roche Ltd.
    Pfizer, Inc.
    Sanofi S.A.
    Alexion Pharmaceuticals, Inc.
    Eli Lilly and Company
    Novo Nordisk A/S
    AstraZeneca
    Eisai Co., Ltd.
    Daiichi Sankyo Company Limited
    Bayer AG
    GlaxoSmithKline
    Merck & Co., Inc.
    Johnson & Johnson
    Biogen, Inc.
    Shire
    Amgen, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Oncology
    Gastrointestinal
    Pulmonary
    Neurology
    Hematology
    Cardio-vascular
    Metabolic disorders
    Endocrinology
    Infectious diseases
    Others

By Application, the market can be split into
    Hospital Pharmacies
    Speciality Pharmacies
    Retail pharmacies
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Orphan Drugs Market Professional Survey Report 2017
1 Industry Overview of Orphan Drugs
    1.1 Definition and Specifications of Orphan Drugs
        1.1.1 Definition of Orphan Drugs
        1.1.2 Specifications of Orphan Drugs
    1.2 Classification of Orphan Drugs
        1.2.1 Oncology
        1.2.2 Gastrointestinal
        1.2.3 Pulmonary
        1.2.4 Neurology
        1.2.5 Hematology
        1.2.6 Cardio-vascular
        1.2.7 Metabolic disorders
        1.2.8 Endocrinology
        1.2.9 Infectious diseases
        1.2.10 Others
    1.3 Applications of Orphan Drugs
        1.3.1 Hospital Pharmacies
        1.3.2 Speciality Pharmacies
        1.3.3 Retail pharmacies
        1.3.4 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Orphan Drugs
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Orphan Drugs
    2.3 Manufacturing Process Analysis of Orphan Drugs
    2.4 Industry Chain Structure of Orphan Drugs

3 Technical Data and Manufacturing Plants Analysis of Orphan Drugs
    3.1 Capacity and Commercial Production Date of Global Orphan Drugs Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Orphan Drugs Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Orphan Drugs Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Orphan Drugs Major Manufacturers in 2016

4 Global Orphan Drugs Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Orphan Drugs Capacity and Growth Rate Analysis
        4.2.2 2016 Orphan Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Orphan Drugs Sales and Growth Rate Analysis
        4.3.2 2016 Orphan Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Orphan Drugs Sales Price
        4.4.2 2016 Orphan Drugs Sales Price Analysis (Company Segment)

5 Orphan Drugs Regional Market Analysis
    5.1 North America Orphan Drugs Market Analysis
        5.1.1 North America Orphan Drugs Market Overview
        5.1.2 North America 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Orphan Drugs Sales Price Analysis
        5.1.4 North America 2016 Orphan Drugs Market Share Analysis
    5.2 China Orphan Drugs Market Analysis
        5.2.1 China Orphan Drugs Market Overview
        5.2.2 China 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Orphan Drugs Sales Price Analysis
        5.2.4 China 2016 Orphan Drugs Market Share Analysis
    5.3 Europe Orphan Drugs Market Analysis
        5.3.1 Europe Orphan Drugs Market Overview
        5.3.2 Europe 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Orphan Drugs Sales Price Analysis
        5.3.4 Europe 2016 Orphan Drugs Market Share Analysis
    5.4 Southeast Asia Orphan Drugs Market Analysis
        5.4.1 Southeast Asia Orphan Drugs Market Overview
        5.4.2 Southeast Asia 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Orphan Drugs Sales Price Analysis
        5.4.4 Southeast Asia 2016 Orphan Drugs Market Share Analysis
    5.5 Japan Orphan Drugs Market Analysis
        5.5.1 Japan Orphan Drugs Market Overview
        5.5.2 Japan 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Orphan Drugs Sales Price Analysis
        5.5.4 Japan 2016 Orphan Drugs Market Share Analysis
    5.6 India Orphan Drugs Market Analysis
        5.6.1 India Orphan Drugs Market Overview
        5.6.2 India 2012-2017E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Orphan Drugs Sales Price Analysis
        5.6.4 India 2016 Orphan Drugs Market Share Analysis

6 Global 2012-2017E Orphan Drugs Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Orphan Drugs Sales by Type
    6.2 Different Types of Orphan Drugs Product Interview Price Analysis
    6.3 Different Types of Orphan Drugs Product Driving Factors Analysis
        6.3.1 Oncology of Orphan Drugs Growth Driving Factor Analysis
        6.3.2 Gastrointestinal of Orphan Drugs Growth Driving Factor Analysis
        6.3.3 Pulmonary of Orphan Drugs Growth Driving Factor Analysis
        6.3.4 Neurology of Orphan Drugs Growth Driving Factor Analysis
        6.3.5 Hematology of Orphan Drugs Growth Driving Factor Analysis
        6.3.6 Cardio-vascular of Orphan Drugs Growth Driving Factor Analysis
        6.3.7 Metabolic disorders of Orphan Drugs Growth Driving Factor Analysis
        6.3.8 Endocrinology of Orphan Drugs Growth Driving Factor Analysis
        6.3.9 Infectious diseases of Orphan Drugs Growth Driving Factor Analysis
        6.3.10 Others of Orphan Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Orphan Drugs Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Orphan Drugs Consumption by Application
    7.2 Different Application of Orphan Drugs Product Interview Price Analysis
    7.3 Different Application of Orphan Drugs Product Driving Factors Analysis
        7.3.1 Hospital Pharmacies of Orphan Drugs Growth Driving Factor Analysis
        7.3.2 Speciality Pharmacies of Orphan Drugs Growth Driving Factor Analysis
        7.3.3 Retail pharmacies of Orphan Drugs Growth Driving Factor Analysis
        7.3.4 Others of Orphan Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Orphan Drugs
    8.1 Novartis AG
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Novartis AG 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Novartis AG 2016 Orphan Drugs Business Region Distribution Analysis
    8.2 Bristol-Myers Squibb Company
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Bristol-Myers Squibb Company 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Bristol-Myers Squibb Company 2016 Orphan Drugs Business Region Distribution Analysis
    8.3 Celgene Corporation
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Celgene Corporation 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Celgene Corporation 2016 Orphan Drugs Business Region Distribution Analysis
    8.4 F. Hoffmann-La Roche Ltd.
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 F. Hoffmann-La Roche Ltd. 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 F. Hoffmann-La Roche Ltd. 2016 Orphan Drugs Business Region Distribution Analysis
    8.5 Pfizer, Inc.
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Pfizer, Inc. 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Pfizer, Inc. 2016 Orphan Drugs Business Region Distribution Analysis
    8.6 Sanofi S.A.
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Sanofi S.A. 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Sanofi S.A. 2016 Orphan Drugs Business Region Distribution Analysis
    8.7 Alexion Pharmaceuticals, Inc.
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Alexion Pharmaceuticals, Inc. 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Alexion Pharmaceuticals, Inc. 2016 Orphan Drugs Business Region Distribution Analysis
    8.8 Eli Lilly and Company
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Eli Lilly and Company 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Eli Lilly and Company 2016 Orphan Drugs Business Region Distribution Analysis
    8.9 Novo Nordisk A/S
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Novo Nordisk A/S 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Novo Nordisk A/S 2016 Orphan Drugs Business Region Distribution Analysis
    8.10 AstraZeneca
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 AstraZeneca 2016 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 AstraZeneca 2016 Orphan Drugs Business Region Distribution Analysis
    8.11 Eisai Co., Ltd.
    8.12 Daiichi Sankyo Company Limited
    8.13 Bayer AG
    8.14 GlaxoSmithKline
    8.15 Merck & Co., Inc.
    8.16 Johnson & Johnson
    8.17 Biogen, Inc.
    8.18 Shire
    8.19 Amgen, Inc.

9 Development Trend of Analysis of Orphan Drugs Market
    9.1 Global Orphan Drugs Market Trend Analysis
        9.1.1 Global 2017-2022 Orphan Drugs Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Orphan Drugs Sales Price Forecast
    9.2 Orphan Drugs Regional Market Trend
        9.2.1 North America 2017-2022 Orphan Drugs Consumption Forecast
        9.2.2 China 2017-2022 Orphan Drugs Consumption Forecast
        9.2.3 Europe 2017-2022 Orphan Drugs Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Orphan Drugs Consumption Forecast
        9.2.5 Japan 2017-2022 Orphan Drugs Consumption Forecast
        9.2.6 India 2017-2022 Orphan Drugs Consumption Forecast
    9.3 Orphan Drugs Market Trend (Product Type)
    9.4 Orphan Drugs Market Trend (Application)

10 Orphan Drugs Marketing Type Analysis
    10.1 Orphan Drugs Regional Marketing Type Analysis
    10.2 Orphan Drugs International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Orphan Drugs by Region
    10.4 Orphan Drugs Supply Chain Analysis

11 Consumers Analysis of Orphan Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Orphan Drugs Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source